| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |